ClinConnect ClinConnect Logo
Search / Trial NCT07144800

Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

Launched by MEMORIAL SLOAN KETTERING CANCER CENTER ·

Trial Information

Current as of September 24, 2025

Recruiting

Keywords

Child Obesity Obesity Weight Loss Memorial Sloan Kettering Cancer Center 25 003

ClinConnect Summary

This clinical trial, called Family COMIDA, is studying the best way to help Hispanic families work together to support healthy eating and weight loss, especially for children facing obesity. The goal is to find a family-centered program where parents and caregivers play an active role in encouraging healthy habits to prevent or reduce obesity.

The study is open to people of all genders, and it focuses on families with children between the ages of 6 and 74 (likely a typo, but usually this means children and possibly their adult caregivers). If you join, you and your family will participate in a program designed to promote better food choices and healthier lifestyles. This could be a good opportunity for families wanting support in making lasting healthy changes together. The trial is currently recruiting participants, so families interested in improving their health through teamwork are encouraged to learn more.

Gender

ALL

Eligibility criteria

About Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.

Locations

Patients applied

0 patients applied

Trial Officials

Jennifer Leng, MD, MPH

Principal Investigator

Memorial Sloan Kettering Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported